CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis

Original Research2021 Apr 2;128(7):908-933.

JOURNAL:Circ Res. Article Link

Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

MS Madhur, F Elijovich, MR Alexander et al. Keywords: T-lymphocytes; autoimmunity; cytokines; dendritic cells; hypertension; immunity; inflammation

Full Text PDF